» Articles » PMID: 10208308

Inhibitory Effects of the Class III Antiarrhythmic Drug Amiodarone on Cloned HERG Potassium Channels

Overview
Specialty Pharmacology
Date 1999 Apr 20
PMID 10208308
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

The human ether-a-go-go-related gene (HERG) encodes a K+ channel with biophysical properties nearly identical to the rapid component of the cardiac-delayed rectifier K+ current (I(Kr)). HERG channels are one primary target for the pharmacological management of arrhythmias. In this study, we investigated the acute effects of the class III antiarrhythmic drug amiodarone on HERG channels expressed heterologously in Xenopus oocytes by use of the two-microelectrode voltage clamp technique. Amiodarone blocked HERG channels with an IC50 of 9.8 microM with a maximum outward tail current reduction of 62.8%. The block consisted of two main components, a closed channel block that could not be reversed within the time of experiments and an open channel block with a slow unblock, having a recovery time constant of 73 s at -80 mV. Inactivation of the HERG channel at very positive potentials could not prevent amiodarone block. These results indicate that HERG channels can be blocked by amiodarone in closed, open and inactivated states. The block of open channels was cumulative, use-dependent and voltage-dependent. In summary, our data suggest that the strong class III antiarrhythmic action of amiodarone is at least partially based upon its acute inhibitory effects on HERG potassium channels.

Citing Articles

Differential Effects of the Betablockers Carvedilol, Metoprolol and Bisoprolol on Cardiac K4.3 (I) Channel Isoforms.

Rahm A, Hackbarth J, Muller M, Pfeiffer J, Gampp H, Petersenn F Int J Mol Sci. 2023; 24(18).

PMID: 37762145 PMC: 10530285. DOI: 10.3390/ijms241813842.


Cardiac hERG K Channel as Safety and Pharmacological Target.

Su S, Sun J, Wang Y, Xu Y Handb Exp Pharmacol. 2021; 267:139-166.

PMID: 33829343 DOI: 10.1007/164_2021_455.


Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty.

Shah R, Stonier P Ther Adv Drug Saf. 2018; 9(8):475-493.

PMID: 30364900 PMC: 6199680. DOI: 10.1177/2042098618780854.


Interactions between amiodarone and the hERG potassium channel pore determined with mutagenesis and in silico docking.

Zhang Y, Colenso C, El Harchi A, Cheng H, Witchel H, Dempsey C Biochem Pharmacol. 2016; 113:24-35.

PMID: 27256139 PMC: 4959829. DOI: 10.1016/j.bcp.2016.05.013.


The class III anti-arrhythmic agent, amiodarone, inhibits voltage-dependent K(+) channels in rabbit coronary arterial smooth muscle cells.

Li H, Kim H, Kim H, Shin S, Jung W, Ha K Naunyn Schmiedebergs Arch Pharmacol. 2016; 389(7):713-21.

PMID: 27030392 DOI: 10.1007/s00210-016-1232-8.